Clinical trial
Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During…
NCT00455624 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00455624 |
|---|---|
| Title | Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer |
| Official title | Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute Brigham and Women's Hospital |
| Status | Completed |
| Study type | Observational |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | Androgen deprivation therapy |
| Enrollment | 60 |
| Start date | Nov 1, 2002 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Apr 4, 2007 |
| Last update posted | Jul 11, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: